Why the study?
Does quinidine cause greater QT prolongation compared to quinine in patients treated for Plasmodium falciparum malaria?
Does quinidine cause greater QT prolongation compared to quinine in patients treated for Plasmodium falciparum malaria?
Quinidine causes significantly greater QT prolongation than quinine at therapeutic plasma concentrations in patients with malaria, though neither showed overt cardiotoxicity.
Answers are grounded in this paper and cite their sources.
Quinidine was associated with greater QT prolongation per concentration than quinine in malaria; leaves open arrhythmia risk and treatment implications.
We recorded electrocardiograms from 31 patients receiving quinine and 14 patients receiving quinidine for the treatment of Plasmodium falciparum malaria. Despite plasma quinine concentrations of up to 20 mg/L, there was no evidence of cardiotoxicity. QT prolongation was considerably greater in the quinidine-treated patients. The mean ratio of change in corrected QT interval to change in plasma concentration (delta QTc%/delta CQ) was 3.2% . mg-1 . L-1 for quinidine, compared to 0.74% . mg-1 . L-1 for quinine (p less than 0.001). T-wave flattening was observed in both groups. Plasma concentrations of quinine cannot be predicted from the EKG, because concentrations within the therapeutic range produced only minor and unpredictable abnormalities.
No takes yet. Share an insight, caveat, or question.
White et al. (1983) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: